Skip to search formSkip to main contentSkip to account menu

haloperidol decanoate

Known as: haloperidol decanoate [Chemical/Ingredient] 
The decanoate ester of haloperidol, a phenylbutylpiperadine derivative with antipsychotic, neuroleptic and antiemetic effects. Haloperidol… 
National Institutes of Health

Related topics

Related topics

19 relations
1 ML haloperidol decanoate 100 MG/ML Injection1 ML haloperidol decanoate 50 MG/ML Injection [Haldol]Bone Marrow DiseasesChild Behavior Disorders

Broader (2)

Antipsychotic AgentsHaloperidol

Narrower (1)

Haldol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial.
IMPORTANCE Long-acting injectable antipsychotics are used to reduce medication nonadherence and relapse in schizophrenia-spectrum… 
Highly Cited
2008
Highly Cited
2008
Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo
Highly Cited
2007
Highly Cited
2007
Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: Role of dopamine transporter
Highly Cited
2006
Highly Cited
2006
Treatment of Schizophrenia With Long-Acting Fluphenazine, Haloperidol, or Risperidone
Objective: This study compares 3 cohorts of patients with schizophrenia before, during, and after initiating treatment with… 
Highly Cited
2005
Highly Cited
2005
Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol
Highly Cited
2002
Highly Cited
2002
A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia.
OBJECTIVE Maintenance medication is critical in the prevention of psychotic relapse and rehospitalization among patients with… 
Highly Cited
2000
Highly Cited
2000
Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia.
BACKGROUND Markers of gamma-aminobutyric acid (GABA) neurotransmission seem to be altered in the prefrontal cortex (PFC) of… 
Highly Cited
1997
Highly Cited
1997
Delayed normalization of central D2 dopamine receptor availability after discontinuation of haloperidol decanoate. Preliminary findings.
BACKGROUND Antipsychotic drugs in depot formulations may prevent psychotic relapses, even after complete withdrawal. To examine… 
1996
1996
Test-retest reliability of central [11C]raclopride binding at high D2 receptor occupancy. A PET study in haloperidol-treated patients
Highly Cited
1992
Highly Cited
1992
D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)